Delynov Chirurgie, Delynov Incarcerated Swan-Ganz catheter: a pitfall of left atriotomy in MICS The use of the pulmonary artery catheter (PAC) remains a common practice for continuous hemodynamic monitoring in cardiac surgery. However, this technique is not... Oct 16, 2025
Delynov Chirurgie, Delynov Stroke and negative cultures: imaging detects endocarditis on annuloplasty Infective endocarditis (IE) on prosthetic material or repaired valves represents a major diagnostic challenge, particularly when the modified Duke criteria prove inconclusive. Oct 16, 2025
Delynov Chirurgie, Delynov Mitral Valve Repair: Precision at the Heart of Robotics and Transcatheter Techniques Mitral regurgitation (MR) is the second most common valvular heart disease in developed countries, affecting over three million people in the United States. It repre... Oct 14, 2025
Delynov Chirurgie, Delynov Rigid ring or flexible band: which tricuspid annuloplasty to prioritize? During left-sided valve surgery, concomitant correction of functional tricuspid regurgitation is currently recommended to optimize clinical outcomes. Oct 13, 2025
Delynov Chirurgie, Delynov Mitral valve repair or replacement: criteria for the right choice Management of severe primary mitral regurgitation (defined by a vena contracta > 0.7 cm or a regurgitant volume > 60 ml) prioritises surgical repair. Oct 13, 2025
Delynov Chirurgie, Delynov Type A dissection: how not to miss this false right-sided infarction Acute type A aortic dissection (ATAAD) remains a major diagnostic challenge due to the polymorphism of its clinical presentations. This case report documents the management... Oct 12, 2025
Delynov Chirurgie, Delynov Secondary MR: surgery reduces mortality by 26% compared to TEER Secondary mitral regurgitation (SMR) represents a major therapeutic challenge, affecting over 24 million people with a significant morbidity burden. This clinical overview examines current management strategies and emerging treatments. Oct 9, 2025
Delynov Chirurgie, Delynov Mitral Regurgitation: Surgery Superior to TEER in the Medium Term Secondary mitral regurgitation (SMR), affecting approximately 24.2 million people worldwide, represents a major challenge in cardiology with a burden of 34,000 deaths. Oct 9, 2025
Delynov Chirurgie, Delynov TEER: the PASCAL system, a serious alternative in mitral repair Severe mitral regurgitation (MR), when left untreated, leads to significant morbidity and mortality. In patients at prohibitive surgical risk, transcatheter edge-to-edge repair... Oct 8, 2025
Delynov Chirurgie, Delynov TMVr: why do minorities have less access to mitral repair? While ethnic disparities are well-established in interventional cardiology, their specific impact on transcatheter mitral valve repair (TMVr) remains insufficiently explored. This study provides a detailed analysis of clinical outcomes and access to care. Oct 7, 2025
Delynov Chirurgie, Delynov Mitral surgery: equivalent survival between sexes despite highly varied profiles Mitral valve disease (MVD) remains the second most prevalent valvular pathology in Europe. In Germany, the epidemiology has shifted radically over two decades: while... Oct 7, 2025
Delynov Chirurgie, Delynov BioChord: the first biomimetic substitute for mitral chordae tendineae Chordae tendineae (CT) replacement using expanded polytetrafluoroethylene (ePTFE) sutures currently represents the clinical standard in cardiac surgery. However... Oct 6, 2025
